Metraipolis › archive › dc_228d799ae43f
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis — Europe PMC PMID:41504936
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41504936
- DOI
- 10.1007/s00432-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:31:49.913Z
- SHA-256 of the archived text
97b3769ee01a0dd96195f979bcecd250bbb1d27238758269ccb2afc8a0417356- Stable URL of this page
https://metraipolis.com/documento/dc_228d799ae43f
How to cite
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis — Europe PMC PMID:41504936 — Europe PMC (en), https://europepmc.org/article/MED/41504936 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_228d799ae43f (Metraipolis archive dc_228d799ae43f, sha256 97b3769ee01a0dd96195f979bcecd250bbb1d27238758269ccb2afc8a0417356)
BibTeX
@misc{dc228d799ae43f,
title = {Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis — Europe PMC PMID:41504936},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41504936},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_228d799ae43f; sha256 97b3769ee01a0dd96195f979bcecd250bbb1d27238758269ccb2afc8a0417356},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41504936. Agents can read the archived copy with the MCP tool read_document.